Mon.Jan 27, 2025

article thumbnail

FDA Updates Viloxazine Label for ADHD

Pharmacy Times

Based on the updated label, new pharmacodynamic data have been added for a better understanding of the drug for individuals with attention-deficit/hyperactivity disorder (ADHD).

Labelling 122
article thumbnail

GSK backs £50m Oxford University cancer vaccine programme

pharmaphorum

A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.

Vaccines 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Approves Lecanemab-Irmb Maintenance Dosing for Early Alzheimer Disease Treatment

Pharmacy Times

Administered every 4 weeks, the approval could serve as a breakthrough for easier and more effective care for patients with early Alzheimer disease.

FDA 110
article thumbnail

An ALS treatment wave is approaching, and this biotech CEO is ready to surf

PharmaVoice

Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.

105
105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Navigating the Challenges of Bispecific Antibodies in Relapsed and Refractory Multiple Myeloma

Pharmacy Times

Managing bispecific antibodies requires collaboration and meticulous protocols.

109
109
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Aligned Marketplace launched in 2023 to offer an advanced primary care marketplace for self-insured employers. The company offers employers access to a national network with more than 3,000 locations and coverage in all 50 states.

Insurance 104

More Trending

article thumbnail

Pfizer offers $60m to settle prescriber kickback claims

pharmaphorum

Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.

102
102
article thumbnail

Adderall Shortage Led to More Alternative Stimulant Prescriptions for US Children

Drug Topics

Researchers analyzed overall prescription stimulant dispensing trends among US children from 2017 to 2023.

98
article thumbnail

Pfizer settles Biohaven kickback claims case for $59.7m

Pharmaceutical Technology

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.

98
article thumbnail

Pharmacists Can Play Important Role in Contraceptive Services

Drug Topics

A discussion with Natalie DiPietro Mager, PharmD, PhD, on how community pharmacists can improve access to contraceptive services.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Ascentage raises $126m in first biotech IPO of 2025

pharmaphorum

China's Ascentage completes the first US biotech IPO of 2025, raising $126m for its pipeline of small-molecule cancer drugs.

98
article thumbnail

Q&A: How Health Systems Must Navigate Pharmacy, Medical Benefits

Drug Topics

Eric Tichy, PharmD, MBA, sat down with Drug Topics to discuss challenges within the business behind health-system pharmacies.

98
article thumbnail

Six life sciences real estate trends to watch in 2025

pharmaphorum

Stay ahead of the game by keeping an eye on these six life sciences real estate trends to watch in 2025. From AI integration to collaborative incubator spaces, the industry is evolving rapidly.

97
article thumbnail

The Role of Antivirals in Managing RSV Infections

Pharmacy Times

Antiviral treatments for respiratory viruses such as respiratory syncytial virus (RSV) are crucial, especially with the rise of the "triple-demic.

97
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

UK biotech Swarm lands with a T-cell therapy mission

pharmaphorum

UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.

83
article thumbnail

Poll Shows 11% of Patients Did Not Plan on Getting 2024-2025 Respiratory Vaccination

Pharmacy Times

Approximately 66% of patients received a COVID-19 vaccine in the fall of 2024 and only 26% received a respiratory syncytial virus vaccine.

article thumbnail

Does propranolol make you sleepy?

The Checkup by Singlecare

Propranolol is a generic prescription medication sold under different brand names, such as Inderal LA, Inderal XL, Hemangeol, and InnoPran XL. It is used to treat cardiovascular conditions such as high blood pressure, conditions that cause irregular heartbeat, heart failure, and heart attacks. Propranolol belongs to a class of medication called beta blockers.

Dosage 78
article thumbnail

Cardiovascular Risk Factors Increase Thrombosis, Mortality in Patients With Myelofibrosis, Other MPNs

Pharmacy Times

Patients with myelofibrosis have a higher likelihood of having a cardiovascular risk factor when compared with essential thrombocythemia or polycythemia vera.

73
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The biggest cause of death in the U.S. remains the same

STAT

  Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here.

71
article thumbnail

Health Care Providers and Patients Have Differing Views on Asthma Remission

Pharmacy Times

Remission is a new emphasis and treatment goal for the management of asthma.

73
article thumbnail

Natural killer cells, a rising alternative to CAR-T cell therapy

PharmaVoice

These innate immune cells may provide a safer, lower-cost option in cancer and autoimmune diseases.

article thumbnail

Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech

Pharmaceutical Technology

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.

69
article thumbnail

A Review of Axatilimab in Steroid Refractory Chronic Graft versus Host Disease

Pharmacy Times

Axatilimab-csfr is a colony-stimulating factor-1 receptor (CSFR1) blocking monoclonal antibody indicated for cGVHD after 2 or more lines of prior therapy in adults and pediatric patients that weigh at least 40 kg.

65
article thumbnail

The AI advantage in discovering new medicines 

Pharmaceutical Technology

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

64
article thumbnail

Study Links Racism With Increased Risk of High Postpartum Blood Pressure

Pharmacy Times

Although the research focused on Black communities in the United States, there is also evidence linking racism and blood pressure for patients who are Asian or Hispanic.

65
article thumbnail

Italian decision sets up launch of Oncopeptides' Pepaxti

pharmaphorum

Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.

63
article thumbnail

The Evolving Role of Pharmacovigilance in Digital Therapeutics

Pharmacy Times

Digital therapeutics (DTx), a novel evidence-based software approach, is revolutionizing health care by delivering personalized treatments. Pharmacovigilance ensures DTx safety but faces challenges such as data privacy and standardization.

65
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The "broad framework" outlined by the partners would address healthcare issues in the state, such as high costs and workforce shortages, with $1 billion of new investments over the next half decade.

59
article thumbnail

Study: Bile Acid Supplement Shows Promise for Liver Cancer

Pharmacy Times

Boosting ursodeoxycholic acid (UDCA) levels through dietary supplementation was shown to control tumor growth in mice with liver cancer.

65
article thumbnail

FDA Accepts Review of Golimumab Biosimilar

Pharmaceutical Commerce

Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions.

FDA 59
article thumbnail

Pharmacy Quality Alliance Elects 2025 Board of Directors and Executive Committee

Pharmacy Times

Four New Members from Diverse Health Care Professions, Organizations and Industries Join Board

65
article thumbnail

MSD wins FDA priority review for Welireg in rare endocrine cancer

Pharmaceutical Technology

If approved, Welireg would be the only available therapy in the US for eligible patients with advanced PPGL.

FDA 59
article thumbnail

Improving Outcomes Through Patient Education and Addressing Unmet Needs

Pharmacy Times

Panelists discuss how comprehensive patient education about tardive dyskinesia risk factors, early warning signs, and available treatments is crucial for improving outcomes, while highlighting remaining unmet needs including better screening tools, enhanced provider training, expanded access to VMAT2 inhibitors, and more research into prevention strategies and novel therapeutic approaches.

65